BILLS-116hr5501ih.pdf
House Resolutions
0 pages
Page
of 0
Loading OCR text...
No OCR text available for this page.
Failed to load OCR text.
DATE (15)
20:16 Jan 06
2020
6-year
later than 1 year
1ST SESSION H. R. 5501
2019
1 year
3 years
6 months of the date
DECEMBER 19, 2019
later than 3 years
1995
the previous 5-year
that year
annually
EVENT (1)
the ‘‘Affordable Drug
FAC (15)
PO 00000
Frm 00006
PO 00000
PO 00000
Frm 00005
PO 00000
Frm 00007
PO 00000
Frm
PO 00000
Frm 00009
PO 00000
Frm 00003
Fmt
PO 00000
Frm 00015
PO 00000
Frm 00001
PO 00000
Frm 00004
PO 00000
Frm 00008
Fmt
PO 00000
Frm 00002
PO 00000
Frm 00013
Fmt
PO 00000
Frm 00010
PO 00000
Frm 00011
Fmt
GPE (2)
United States
the United States of America
LOC (2)
IH
United
ORG (35)
Office
the Federal Food, Drug
the Public Health Service Act
Senate
Federal and State
the Centers for Disease Control and Prevention
Food and Drug Administration
the Public Health Service
United
SEC
Federal Food, Drug
Food, Drug
the Department of Health and Human Services
the ‘Office’
nual
the Food and Drug Administration
THE HOUSE OF REPRESENTATIVES
Congress
Bureau of Labor Statistics
Office of Drug Manufacturing
Health, Education
House of Representa-
Labor
the World Health
the Food and Drug Admin-
the Office of Drug Manufac-
the
Committee on Energy and Commerce
ENTS
the Committee on Energy
the Bureau of Labor
Federal
an Office of Drug
Manufacturing
Federal Government
PERSON (1)
SCHAKOWSKY
Topic Classifications
congressional legislation
97.9%
government oversight
84.9%
public health
71.9%
Extracted Keywords
manufacture
drugs
drug
covered entity
office shall
manufacturing
appli cable
price
general office
authorized section
establish office
cable
office
director office
tracts
Forensic Analysis
PDF Metadata
- Creator
- ACOMP.exe WinVer 2.2a Sep 11 2014
- ModDate
- D:20230101062616Z
- Producer
- Acrobat Distiller 19.0 (Windows); modified using iText® Core 7.2.3 (production version) ©2000-2022 iText Group NV, Government Publishing Office
- CreationDate
- D:20200106205140-05'00'
Sentiment
Polarity
Positive
0.111
Subjectivity
36%
Objective